Vir Biotechnology (VIR) Enterprise Value (2019 - 2026)
Vir Biotechnology's Enterprise Value came in at $1.2 billion for Q2 2026, compared with $101.24 million a year earlier and up 22.7% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Enterprise Value (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vir Biotechnology reported Enterprise Value of -$233.8 million; for FY2025, it came in at $380.1 million, up 264.5% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $104.28 million in FY2024, -$156.66 million in FY2023, $1 billion in FY2022 (-79.7%) and $4.93 billion in FY2021 (+84.2%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q2 2023.
- Year-over-year, Enterprise Value increased in four of the last five quarters, with growth averaging 250.6%.
- The fastest year-over-year change in Enterprise Value over five years came in Q1 2026 (growth of 839.3%), and the weakest in Q2 2024 (a decline of 95.3%).
- Business Quant data shows VIR's Enterprise Value at $974.22 million (Q1 2026), $380.1 million (Q4 2025) and $295.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 974.22 Mn |
| Dec 31, 2025 | 380.10 Mn |
| Sep 30, 2025 | 295.99 Mn |
| Jun 30, 2025 | 101.24 Mn |
| Mar 31, 2025 | 103.71 Mn |
| Dec 31, 2024 | 104.28 Mn |
| Sep 30, 2024 | 114.97 Mn |
| Jun 30, 2024 | 68.95 Mn |
| Mar 31, 2024 | 230.26 Mn |
| Dec 31, 2023 | -156.66 Mn |
| Sep 30, 2023 | -425.48 Mn |
| Jun 30, 2023 | 1.46 Bn |
| Mar 31, 2023 | 885.13 Mn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 241.09 Mn |
| Jun 30, 2022 | 1.22 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 4.93 Bn |
| Sep 30, 2021 | 4.92 Bn |
API Access
Vir Biotechnology Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();